表紙
市場調査レポート

睡眠時無呼吸症関連機器の世界市場 〜2020年:装置 (診断機器/治療機器) 別・エンドユーザー別の分析と将来予測

Sleep Apnea Devices Market by Product, Diagnostic (PSG, Pulse Oximeter), Therapeutic [CPAP, APAP, BPAP, Masks, Oral Appliances (Mandibular Advancement Device)], End User (Home Care Settings, Hospitals) - Analysis & Global Forecasts to 2020

発行 MarketsandMarkets 商品コード 247572
出版日 ページ情報 英文 168 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
睡眠時無呼吸症関連機器の世界市場 〜2020年:装置 (診断機器/治療機器) 別・エンドユーザー別の分析と将来予測 Sleep Apnea Devices Market by Product, Diagnostic (PSG, Pulse Oximeter), Therapeutic [CPAP, APAP, BPAP, Masks, Oral Appliances (Mandibular Advancement Device)], End User (Home Care Settings, Hospitals) - Analysis & Global Forecasts to 2020
出版日: 2015年07月29日 ページ情報: 英文 168 Pages
概要

世界の睡眠時無呼吸症向け診断・治療機器の市場規模は、2015年には37億米ドル、2020年には53億米ドルに達し、また2015〜2020年の年平均成長率 (CAGR) は7.2%となる、と推計されています。そのうち治療機器の場合は、医療費償還制度の改善や社会的認知度の拡大を受けて、口腔装置が2桁台の成長を遂げる見込みです。エンドユーザー別では、在宅治療向け機器が急速な拡大を遂げています。地域別では北米が最大の市場ですが、欧州市場も (医療費償還改善・認知度拡大により) 急激に成長する見通しです。

当レポートでは、睡眠時無呼吸症関連機器 (診断/治療装置) の世界市場について分析し、市場の基本的構造や最新動向、主な市場促進・阻害要因、市場規模の動向見通し (今後6年間分)、製品別・エンドユーザー別・地域別の詳細動向、市場競争の状態、今後の技術開発・市場発展の方向性、主要企業のプロファイルなどを調査・考察しております。

第1章 イントロダクション

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場の内訳
  • 市場のダイナミクス
    • 促進要因
      • 北米:睡眠時無呼吸症の悪影響に対する認知度の上昇
      • カナダ:睡眠時無呼吸症患者向け税額控除
      • 米国:多くの州が睡眠時無呼吸症に関する警告声明を発表
      • 多数の未診断の睡眠時無呼吸症患者の存在
      • 睡眠時無呼吸症の放置は医療費の増大を招く
      • 睡眠時無呼吸症の合併症
    • 抑制要因
      • 医療費償還額の不足
      • 患者コンプライアンスの欠如
      • 代替療法
    • 市場機会
      • 肥満患者の増加
      • 睡眠時無呼吸症の治療を通じた収益の改善:企業の間で人気を博す
      • ベンチャーキャピタル (VC) からの多額の資金提供
      • 革新的な製品パイプライン
      • 睡眠時無呼吸症/口腔装置の市場に参入する企業

第6章 世界の睡眠時無呼吸症診断機器市場:製品別

  • イントロダクション
  • 睡眠ポリグラフ計 (PSG) 装置
    • 臨床用PSG装置
    • 外来用PSG装置
  • 呼吸ポリグラフ計
  • 単経路スクリーニング装置 (パルスオキシメーター)
    • 携帯型パルスオキシメーター
    • 指先型パルスオキシメーター
    • 卓上型パルスオキシメーター
    • 腕輪型パルスオキシメーター
  • アクティグラフシステム

第7章 世界の睡眠時無呼吸症治療機器市場:製品別

  • イントロダクション
  • 陽性気道圧 (PAP) 装置
    • 持続陽性気道圧 (CPAP) 装置
    • 自動陽性気道圧 (APAP) 装置
    • バイレベル陽性気道圧 (BPAP) 装置
  • フェイシャルインターフェース
    • マスク
    • フルフェイスマスク
    • 鼻マスク
    • 鼻ピローマスク
  • 適応補助換気 (ASV)
  • 気道クリアランスシステム
  • 酸素濃縮器
    • 据置型酸素濃縮器
    • 携帯型酸素濃縮器
  • アクセサリー
    • ピロー (枕)
    • マスク清掃用ワイプ
    • 顎用バンド
    • その他
  • 口腔装置
    • 下顎前方固定装置
    • 舌維持装置
  • 代替療法
    • 生活習慣の改善
    • 鍼療法
    • 位置療法

第8章 世界の睡眠時無呼吸症治療機器市場:エンドユーザー別

  • イントロダクション
  • 在宅治療向け市場
  • 睡眠試験室 (sleep laboratory)・病院向け市場

第9章 睡眠時無呼吸症治療機器市場:地域別

  • イントロダクション
  • 北米 (米国など)
  • 欧州 (フランス・英国など)
  • アジア太平洋地域 (日本・中国・オーストラリア・ニュージーランドなど)
  • その他の地域 (ROW) (ブラジルなど)

第10章 競争環境

  • 概要
  • 市場シェア分析
  • 競争状況と動向
    • 新製品の発売
    • 事業協力・契約・事業提携
    • 企業買収
    • 事業拡張
    • その他

第11章 企業プロファイル (概要、財務状況、製品・サービス、戦略、近年の動向)

  • PHILIPS HEALTHCARE
  • RESMED, INC.
  • FISHER & PAYKEL HEALTHCARE LTD
  • SOMNOMED LIMITED
  • COMPUMEDICS LIMITED
  • DEVILBISS HEALTHCARE
  • BMC MEDICAL CO., LTD.
  • BRAEBON MEDICAL CORPORATION
  • WEINMANN MEDICAL DEVICES GMBH
  • WHOLE YOU, INC.

第12章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 1181

The sleep apnea devices market is currently witnessing a strong focus on innovation. Many established market players such as ResMed, Inc. (U.S.) and new entrants such as Airing LLC (U.S.) are focusing on innovation. Efforts by new and established players in the market have led to the development of a strong pipeline of products that are expected to better serve sleep apnea patients. This rich pipeline of innovative products is likely to open an array of opportunities for the sleep apnea market.

In 2015, therapeutic devices type segment is expected to account for the largest share in the market and grow at the highest rate; the home care settings segment is expected to account for the largest share of the sleep apnea devices market, by end user.

In 2015, North America accounted for the largest share of the global sleep apnea devices market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, the sleep apnea devices market is expected to witness the highest growth rate in Europe; this can be attributed to increased awareness on sleep apnea and the improving reimbursement scenario in the region. Furthermore, the intervention of the government and trade associations to address untreated sleep apnea will act as an additional growth driver in the region.

The sleep apnea devices market comprises a few large players and several small players. Technological advancements, the availability of new products for the treatment of sleep apnea, and evolving industry standards are propelling the growth of this market. New product launches was the key growth strategies adopted by players in the sleep apnea devices market. This strategy was employed by players to widen and strengthen their product portfolios. Acquisitions and collaborations, agreements, and partnerships were other key areas of focus for market players.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned seven strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • New Product Launches: Comprehensive information on the product portfolios offered by top players in the sleep apnea devices market.
  • Acquisitions: Detailed insights on the acquisitions undertaken by the players in the market and their impacts
  • Collaborations, Agreements, and Partnerships: Comprehensive information about collaborations, agreements, and partnerships undertaken by players in the market and their objectives.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. PACKAGE SIZE
  • 1.6. LIMITATIONS
  • 1.7. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key industry insights
      • 2.2.2.2. Key data from primary sources
      • 2.2.2.3. Key Insights from primary sources
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. MARKET FORECAST METHODOLOGY
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. SLEEP APNEA DEVICES MARKET, BY TYPE
  • 3.3. SLEEP APNEA DEVICES MARKET, BY END USER
  • 3.4. GEOGRAPHICAL SNAPSHOT OF THE SLEEP APNEA DEVICES MARKET
  • 3.5. COMPETITIVE LANDSCAPE: SLEEP APNEA DEVICES MARKET
  • 3.6. OUTLOOK: SLEEP APNEA DEVICES MARKET

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL SLEEP APNEA DEVICES MARKET OVERVIEW
  • 4.2. SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY REGION AND TYPE
  • 4.3. GEOGRAPHICAL SNAPSHOT OF THE SLEEP APNEA DEVICES MARKET
  • 4.4. SLEEP APNEA THERAPUETIC DEVICES MARKET, BY TYPE (2015)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Growing awareness regarding the ill effects of untreated sleep apnea in North America
      • 5.3.1.2. Disability Tax Credit for sleep apnea in Canada
      • 5.3.1.3. Sleep apnea awareness proclamations by various states in the U.S.
      • 5.3.1.4. Large pool of undiagnosed sleep apnea patients
      • 5.3.1.5. Untreated sleep apnea leads to higher healthcare costs
      • 5.3.1.6. Complications of sleep apnea
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Lack of reimbursements
      • 5.3.2.2. Lack of patient compliance
      • 5.3.2.3. Alternative treatments for sleep apnea
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Rise in obesity
      • 5.3.3.2. Improvement in bottom line by addressing sleep apnea has gained Popularity among corporations
      • 5.3.3.3. Influx of VC funding
      • 5.3.3.4. Innovative product pipeline
      • 5.3.3.5. Companies venturing into the sleep apnea and oral appliances market

6. GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. POLYSOMNOGRAPHY (PSG) DEVICES
    • 6.2.1. CLINICAL PSG DEVICES
    • 6.2.2. AMBULATORY PSG DEVICES
  • 6.3. RESPIRATORY POLYGRAPHS
  • 6.4. SINGLE-CHANNEL SCREENING DEVICES (PULSE OXIMETERS)
    • 6.4.1. HANDHELD PULSE OXIMETERS
    • 6.4.2. FINGERTIP PULSE OXIMETERS
    • 6.4.3. TABLETOP PULSE OXIMETERS
    • 6.4.4. WRIST-WORN PULSE OXIMETERS
  • 6.5. ACTIGRAPHY SYSTEMS

7. GLOBAL SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCTS

  • 7.1. INTRODUCTION
  • 7.2. POSITIVE AIRWAY PRESSURE (PAP) DEVICE
    • 7.2.1. CPAP DEVICES
    • 7.2.2. APAP DEVICES
    • 7.2.3. BPAP DEVICES
  • 7.3. FACIAL INTERFACES
    • 7.3.1. MASKS
    • 7.3.2. FULL-FACE MASKS
    • 7.3.3. NASAL MASKS
    • 7.3.4. NASAL PILLOW MASKS
  • 7.4. ADAPTIVE SERVO-VENTILATION (ASV)
  • 7.5. AIRWAY CLEARANCE SYSTEMS
  • 7.6. OXYGEN CONCENTRATORS
    • 7.6.1. STATIONARY CONCENTRATORS
    • 7.6.2. PORTABLE CONCENTRATORS
  • 7.7. ACCESSORIES
    • 7.7.1. PILLOWS
    • 7.7.2. MASK CLEANING WIPES
    • 7.7.3. CHIN RESTRAINTS
    • 7.7.4. OTHERS
  • 7.8. ORAL APPLIANCES
    • 7.8.1. MANDIBULAR ADVANCEMENT DEVICES
    • 7.8.2. TONGUE RETAINING DEVICE
      • 7.8.2.1. Technological advancements
      • 7.8.2.2. Awareness initiatives by stakeholders
      • 7.8.2.3. Advantages of oral appliance therapy
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. Increase in dental courses offered
  • 7.9. ALTERNATE THERAPIES
    • 7.9.1. LIFESTYLE CHANGES
    • 7.9.2. ACUPUNCTURE
    • 7.9.3. POSITIONAL THERAPY

8. SLEEP APNEA DEVICES MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. HOME CARE SETTINGS
  • 8.3. SLEEP LABORATORIES AND HOSPITALS

9. SLEEP APNEA DEVICES MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. SHIFTING TRENDS IN SLEEP TESTING IN THE U.S.
    • 9.2.2. ORAL APPLIANCES GAINING IMPORTANCE
    • 9.2.3. U.S. FEDERAL AVIATION ADMINISTRATION AIMS TO ADDRESS AVIATION ACCIDENTS BY ISSUING NEW GUIDELINES FOR SLEEP APNEA
    • 9.2.4. INCREASING ATTENTION TO PEDIATRIC SLEEP APNEA
  • 9.3. EUROPE
    • 9.3.1. VARYING REIMBURSEMENT SCENARIO IN EUROPE
    • 9.3.2. CONFERENCES & SYMPOSIA
    • 9.3.3. NEW LEGISLATION LIKELY TO BOOST CPAP DEMAND
    • 9.3.4. STRICTER MANDATES IN FRANCE
    • 9.3.5. LAUNCH OF NEW OSA TOOLKIT TO IMPROVE THE DIAGNOSIS AND TREATMENT OF OSA IN THE U.K.
  • 9.4. ASIA PACIFIC
    • 9.4.1. LACK OF REIMBURSEMENT FOR ORAL APPLIANCES
    • 9.4.2. RISE IN OBESITY
    • 9.4.3. UNFAVORABLE MARKET SCENARIO IN JAPAN
    • 9.4.4. INADEQUATE SAS SCREENING INITIATIVES IN JAPAN
    • 9.4.5. FAVORABLE RESEARCH LANDSCAPE IN JAPAN
    • 9.4.6. CARDIOLOGISTS TREATING SLEEP DISORDERS IN HEART PATIENTS
    • 9.4.7. AWARENESS PROGRAMS SET TO EDUCATE THE INDIAN MARKET
    • 9.4.8. CHINA: AWARENESS OF SLEEP DISORDERS AND RISE IN SLEEP CLINICS
    • 9.4.9. AWARENESS INITIATIVES IN AUSTRALIA AND NEW ZEALAND
  • 9.5. REST OF THE WORLD (ROW)
    • 9.5.1. GROWTH BARRIER: BRAZIL'S DEVELOPED ACUPUNCTURE CULTURE
    • 9.5.2. WEAK ECONOMY AND LOW CONSUMER BUYING POWER
    • 9.5.3. GROWING AWARENESS ON SLEEP APNEA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. NEW PRODUCT LAUNCHES
    • 10.3.2. COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS
    • 10.3.3. ACQUISITIONS
    • 10.3.4. EXPANSIONS
    • 10.3.5. OTHERS

11. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 11.1. PHILIPS HEALTHCARE
  • 11.2. RESMED, INC.
  • 11.3. FISHER & PAYKEL HEALTHCARE LTD
  • 11.4. SOMNOMED LIMITED
  • 11.5. COMPUMEDICS LIMITED
  • 11.6. DEVILBISS HEALTHCARE
  • 11.7. BMC MEDICAL CO., LTD.
  • 11.8. BRAEBON MEDICAL CORPORATION
  • 11.9. WEINMANN MEDICAL DEVICES GMBH
  • 11.10. WHOLE YOU, INC.

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. COMPANY DEVELOPMENTS (2012-2014)
    • 12.2.1. PHILIPS HEALTHCARE
    • 12.2.2. RESMED, INC.
    • 12.2.3. SOMNOMED
    • 12.2.4. DEVILBISS HEALTHCARE
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: PREVALENCE OF SLEEP APNEA IN COMORBIDITIES
  • TABLE 2: COUNTRIES WITH THE HIGHEST HEALTHCARE COST AS A PERCENTAGE OF THEIR GDP:
  • TABLE 3: TOP 5 MEDICAL CONDITIONS IN THE U.S., BY COST TO ECONOMY:
  • TABLE 4: COMPLICATIONS CAUSED BY SLEEP APNEA
  • TABLE 5: INCREASING AWARENESS REGARDING THE ILL EFFECTS OF UNTREATED SLEEP APNEA IS A MAJOR MARKET DRIVER
  • TABLE 6: LACK OF REIMBURSEMENTS IS A MAJOR HINDRANCE TO THE MARKET
  • TABLE 7: RISING OBESE POPULATION PROVIDES OPPORTUNITIES FOR THE SLEEP APNEA MARKET
  • TABLE 8: GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 9: GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (THOUSAND UNITS)
  • TABLE 10: GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 11: GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 12: GLOBAL POLYSOMNOGRAPHY (PSG) DEVICES MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 13: GLOBAL POLYSOMNOGRAPHY (PSG) DEVICES MARKET SIZE, BY TYPE, 2013-2020 (THOUSAND UNITS)
  • TABLE 14: GLOBAL POLYSOMNOGRAPHY (PSG) DEVICES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 15: GLOBAL POLYSOMNOGRAPHY (PSG) DEVICES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 16: GLOBAL CLINICAL PSG DEVICES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 17: GLOBAL CLINICAL PSG DEVICES MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 18: GLOBAL AMBULATORY PSG DEVICES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 19: GLOBAL AMBULATORY PSG DEVICES MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 20: GLOBAL RESPIRATORY POLYGRAPHS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 21: GLOBAL RESPIRATORY POLYGRAPHS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 22: GLOBAL SINGLE-CHANNEL SCREENING DEVICES MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 23: GLOBAL SINGLE-CHANNEL SCREENING DEVICES MARKET SIZE, BY TYPE, 2013-2020 (THOUSAND UNITS)
  • TABLE 24: GLOBAL SINGLE-CHANNEL SCREENING DEVICES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 25: GLOBAL SINGLE-CHANNEL SCREENING DEVICES MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 26: GLOBAL HANDHELD PULSE OXIMETERS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 27: GLOBAL HANDHELD PULSE OXIMETERS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 28: GLOBAL FINGERTIP PULSE OXIMETERS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 29: GLOBAL FINGERTIP PULSE OXIMETERS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 30: GLOBAL TABLETOP PULSE OXIMETERS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 31: GLOBAL TABLETOP PULSE OXIMETERS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 32: GLOBAL WRIST-WORN PULSE OXIMETERS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 33: GLOBAL WRIST-WORN PULSE OXIMETERS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 34: GLOBAL ACTIGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 35: GLOBAL ACTIGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 36: GLOBAL SLEEP APNEA THERAPEUTIC DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 37: GLOBAL SLEEP APNEA THERAPEUTIC DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (THOUSAND UNITS)
  • TABLE 38: GLOBAL SLEEP APNEA THERAPEUTIC DEVICES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 39: GLOBAL SLEEP APNEA THERAPEUTIC DEVICES MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 40: GLOBAL PAP DEVICES MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 41: GLOBAL PAP DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 (THOUSAND UNITS)
  • TABLE 42: GLOBAL PAP DEVICES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 43: GLOBAL PAP DEVICES MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 44: GLOBAL CPAP DEVICES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 45: GLOBAL CPAP DEVICES MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 46: GLOBAL APAP DEVICES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 47: GLOBAL APAP DEVICES MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 48: GLOBAL BPAP DEVICES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 49: GLOBAL BPAP DEVICES MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 50: GLOBAL MASKS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 51: GLOBAL MASKS MARKET SIZE, BY TYPE, 2013-2020 (THOUSAND UNITS)
  • TABLE 52: GLOBAL MASKS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 53: GLOBAL MASKS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 54: GLOBAL FULL-FACE MASKS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 55: GLOBAL FULL-FACE MASKS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 56: GLOBAL NASAL MASKS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 57: GLOBAL NASAL MASKS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 58: GLOBAL NASAL PILLOW MASKS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 59: GLOBAL NASAL PILLOW MASKS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 60: GLOBAL ADAPTIVE SERVO-VENTILATION MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 61: GLOBAL ADAPTIVE SERVO-VENTILATION MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 62: GLOBAL AIRWAY CLEARANCE SYSTEMS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 63: GLOBAL AIRWAY CLEARANCE SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 64: GLOBAL OXYGEN CONCENTRATORS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 65: GLOBAL OXYGEN CONCENTRATORS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 66: GLOBAL OXYGEN CONCENTRATORS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 67: GLOBAL OXYGEN CONCENTRATORS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 68: GLOBAL STATIONARY CONCENTRATORS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 69: GLOBAL STATIONARY CONCENTRATORS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 70: GLOBAL PORTABLE CONCENTRATORS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 71: GLOBAL PORTABLE CONCENTRATORS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 72: GLOBAL ACCESSORIES MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 73: GLOBAL ACCESSORIES MARKET SIZE, BY TYPE, 2013-2020 (THOUSAND UNITS)
  • TABLE 74: GLOBAL ACCESSORIES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 75: GLOBAL ACCESSORIES MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 76: GLOBAL PILLOWS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 77: GLOBAL PILLOWS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 78: GLOBAL MASK CLEANING WIPES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 79: GLOBAL MASK CLEANING WIPES MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 80: GLOBAL CHIN RESTRAINTS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 81: GLOBAL CHIN RESTRAINTS MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 82: GLOBAL OTHER ACCESSORIES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 83: GLOBAL OTHER ACCESSORIES MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 84: GLOBAL ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 85: GLOBAL ORAL APPLIANCES MARKET SIZE, BY TYPE, 2013-2020 (THOUSAND UNITS)
  • TABLE 86: GLOBAL ORAL APPLIANCES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 87: GLOBAL ORAL APPLIANCES MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 88: GLOBAL MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 89: GLOBAL MANDIBULAR ADVANCEMENT DEVICES MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 90: GLOBAL TONGUE RETAINING DEVICES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 91: GLOBAL TONGUE RETAINING DEVICES MARKET SIZE, BY REGION, 2013-2020 (THOUSAND UNITS)
  • TABLE 92: LIST OF THE ADVANTAGES OF ORAL APPLIANCE:
  • TABLE 93: SLEEP APNEA DEVICES MARKET SIZE, BY END USER, 2013-2020 ($MILLION)
  • TABLE 94: NORTH AMERICA: SLEEP APNEA DEVICES MARKET SIZE, BY END USER, 2013-2020 ($MILLION)
  • TABLE 95: EUROPE: SLEEP APNEA DEVICES MARKET SIZE, BY END USER, 2013-2020 ($MILLION)
  • TABLE 96: ASIA-PACIFIC: SLEEP APNEA DEVICES MARKET SIZE, BY END USER, 2013-2020 ($MILLION)
  • TABLE 97: ROW: SLEEP APNEA DEVICES MARKET SIZE, BY END USER, 2013-2020 ($MILLION)
  • TABLE 98: SLEEP APNEA DEVICES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 99: SLEEP APNEA DIAGNOSTIC DEVICES MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 100: SLEEP APNEA THERAPEUTIC DEVICES MARKET SIZE, BY REGION, 2013 - 2020 ($MILLION)
  • TABLE 101: NORTH AMERICA: SLEEP APNEA DEVICES MARKET SIZE, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 102: NORTH AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 103: NORTH AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 104: NORTH AMERICA: ORAL APPLIANCES MARKET SIZE, BY PRODUCT, 2013-2020 ($MILLION)
  • TABLE 105: EUROPE: SLEEP APNEA DEVICES MARKET SIZE, BY TYPE, 2013 - 2020 ($MILLION)
  • TABLE 106: EUROPE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET SIZE, BY PRODUCT, 2013 - 2020 ($MILLION)
  • TABLE 107: EUROPE: SLEEP APNEA THERAPEUTIC DEVICES MARKET SIZE, BY PRODUCT, 2013 - 2020 ($MILLION)
  • TABLE 108: EUROPE: ORAL APPLIANCES MARKET SIZE, BY PRODUCT, 2013 - 2020 ($MILLION)
  • TABLE 109: ASIA-PACIFIC: SLEEP APNEA DEVICES MARKET SIZE, BY TYPE, 2013 - 2020 ($MILLION)
  • TABLE 110: ASIA-PACIFIC: SLEEP APNEA DIAGNOSTIC DEVICES MARKET SIZE, BY PRODUCT, 2013 - 2020 ($MILLION)
  • TABLE 111: ASIA-PACIFIC: SLEEP APNEA THERAPEUTIC DEVICES MARKET SIZE, BY PRODUCT, 2013 - 2020 ($MILLION)
  • TABLE 112: ASIA-PACIFIC: ORAL APPLIANCES MARKET SIZE, BY PRODUCT, 2013 - 2020 ($MILLION)
  • TABLE 113: ROW: SLEEP APNEA DEVICES MARKET SIZE, BY TYPE, 2013 - 2020 ($MILLION)
  • TABLE 114: ROW SLEEP APNEA DIAGNOSTIC DEVICES MARKET SIZE, BY PRODUCT, 2013 - 2020 ($MILLION)
  • TABLE 115: ROW: SLEEP APNEA THERAPEUTIC DEVICES MARKET SIZE, BY PRODUCT, 2013 - 2020 ($MILLION)
  • TABLE 116: ROW: ORAL APPLIANCES MARKET SIZE, BY PRODUCT, 2013 - 2020 ($MILLION)
  • TABLE 117: NEW PRODUCT LAUNCHES, 2012-2015
  • TABLE 118: COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS, 2012-2015
  • TABLE 119: ACQUISITIONS, 2012-2015
  • TABLE 120: EXPANSIONS, 2012-2015
  • TABLE 121: OTHERS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: GLOBAL SLEEP APNEA DEVICES MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 7: MARKET FORECAST METHODOLOGY
  • FIGURE 8: DATA TRIANGULATION METHODOLOGY
  • FIGURE 9: THERAPEUTIC DEVICES SEGMENT TO DOMINATE THE SLEEP APNEA DEVICES MARKET BY 2020
  • FIGURE 10: HOME CARE SETTINGS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2015
  • FIGURE 11: NORTH AMERICA DOMINATED THE SLEEP APNEA DEVICES MARKET IN 2014
  • FIGURE 12: INCREASING AWARENESS OF SLEEP APNEA AND IMPROVED REIMBURSEMENT SCENARIO IS EXPECTED TO DRIVE MARKET GROWTH
  • FIGURE 13: NORTH AMERICA IS EXPECTED TO DOMINATE THE SLEEP APNEA DIAGNOSTIC DEVICES MARKET IN 2015
  • FIGURE 14: EUROPE TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 15: FACIAL INTERFACES SEGMENT TO EXPERIENCE THE HIGHEST GROWTH RATE IN THE SLEEP APNEA THERAPEUTIC DEVICES MARKET
  • FIGURE 16: SLEEP APNEA DEVICES: MARKET SEGMENTATION
  • FIGURE 17: SLEEP APNEA DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: SINGLE-CHANNEL SCREENING DEVICES EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 19: ORAL APPLIANCES EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 20: HOME CARE SETTING IS EXPECTED TO REGISTER THE FASTEST GROWTH IN THE SLEEP APNEA END USER SEGMENT
  • FIGURE 21: NORTH AMERICA COMMANDED THE LARGEST SHARE OF THE GLOBAL SLEEP APNEA DEVICES MARKET IN 2014
  • FIGURE 22: EUROPE IS SLATED TO REGISTER THE FASTEST GROWTH IN THE SLEEP APNEA DEVICES MARKET 2015-2020
  • FIGURE 23: AUSTRALIA, NEW ZEALAND, AND JAPAN TO DRIVE THE ASIA-PACIFIC MARKET
  • FIGURE 24: ROW SLEEP APNEA DEVICES MARKET IS IN THE INTRODUCTORY STAGE
  • FIGURE 25: NEW PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS (2012-2015)
  • FIGURE 26: GLOBAL SLEEP APNEA DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 27: BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY
  • FIGURE 28: PRODUCT PORTFOLIO ASSESSMENT OF TOP 3 PLAYERS
  • FIGURE 29: PHILIPS HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 30: RESMED, INC.: COMPANY SNAPSHOT
  • FIGURE 31: FISHER & PAYKEL HEALTHCARE LTD.: COMPANY SNAPSHOT
  • FIGURE 32: SOMNOMED LIMITED: COMPANY SNAPSHOT
  • FIGURE 33: COMPUMEDICS LIMITED: COMPANY SNAPSHOT
Back to Top